Here are relevant reports on : competitive-intelligence-market
-
Anomaly Detection Market by Solution (Network and User Behavior Anomaly Detection), Technology (Big Data Analytics, Data Mining and Business Intelligence, Machine Learning and Artificial Intelligence), Deployment, Service, Vertical - Global Forecast to 2022
The anomaly detection market size is expected to grow from USD 2.08 Billion in 2017 to USD 4.45 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 16.4%. The major vendors in the anomaly detection market include Wipro Limited (India), Cisco Systems, Inc. (US), International Business Machines Corporation (US), Hewlett Packard Enterprise Company (US), Dell Technologies, Inc. (US), SAS Institue, Inc. (US), Symantec Corporation (US), Anodot (Israel), Happiest Minds (India), and Guardian Analytics (US).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Geospatial Intelligence Market by GeoAI (Agentic GIS, Model Catalogs), Geospatial Analytics (Traditional GIS Solutions, Location Intelligence, Data Processing & ETL), Acquisition Systems (PNT, GNSS), Technology (Raster, Imagery Analytics) - Global Forecast to 2030
The global geospatial intelligence (GeoAI) market is projected to grow from USD 37.13 billion in 2025 to USD 62.88 billion by 2030, at a CAGR of 11.1% during the forecast period. The Key Players Fugro (Netherlands), Trimble (US), Google (US), Esri (US), Hexagon AB (Sweden), TomTom (Netherlands), IBM (US), Bentley Systems (US), Planet Labs (US), and Ouster (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Generative AI Outlook 2025 – Shaping the Future of Creative Intelligence
Global IT spending on devices, data center systems, enterprise software, IT services, and communications services is forecast to reach USD 5.7 trillion by 2025 (9.3% growth over 2024). OpenAI, Microsoft, Google, AWS, and Adobe are the major players in generative AI, with more than 45% combined market share in 2024. Other prominent market players are NVIDIA, Meta, Anthropic, Accenture, and IBM. In 2024, key generative AI providers strive to maintain their leadership positions with new product launches & product enhancements, multimodal AI advancements, strategic deals, and partnerships & collaborations. In 2025, Generative AI providers will invest in ethical AI frameworks, real-time multimodal capabilities, and AI democratization to enhance usability, address bias, and ensure data security, meeting the growing demand for personalized, transparent, and scalable AI solutions across industries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Cloud Business Intelligence Market: Worldwide Forecasts and Analysis (2014 – 2019)
Cloud Business Intelligence (BI) is a combination of technologies, tools and solutions that employ one or more cloud deployment models. Business intelligence on cloud is a delivery model that is being watched by many organizations as it offers several advantages in terms of cost benefits, flexibility of implementation, availability and speed of implementation. Cloud computing and business intelligence is an ideal match as business intelligence is about transforming data into information that businesses can use to make better decisions, while cloud computing provides an efficient and agile way to access business intelligence solutions. IBM, SAP, SAS, Salesforce.com, Microsoft, and Oracle are the major players in the cloud business intelligence market. These vendors offer their solutions catering to several industry verticals such as BFSI, retail, healthcare and life sciences, IT and telecommunication, government and public sector, research and education, manufacturing, travel and hospitality, media and communication, and others. The report provides global market trends, overall adoption scenario, competitive landscape, key drivers, restraints, concerns and opportunities in this market. The report aims at estimating the current market size and the future growth potential of this market across various verticals and regions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Orthopedic, Cardiovascular, Dental, Surgical), Competitive Landscape (Company Profile, Market share, Company Evaluation Matrix), End User, and Region - Global Forecast to 2030
The global collagen & gelatin market, valued at US$1203.9M in 2024, is forecasted to grow at a 5.8% CAGR, reaching US$1,295.5M by 2025 and US$1,671.3M by 2030. Globally, US is the largest market for collagen and gelatin and this trend is expected to continue during the forecast period
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022
Angiographic catheters market is expected to reach USD 1,402.8 million by 2022 from USD 922.1 million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Increasing number of Cath labs in APAC, incidences of CVDs and preference for minimally invasive surgeries are few of the reasons for the growth of this market
- Published: April 2018
- Price: $ 4950
- TOC Available:
-
Healthcare IT Solutions Market by Product (EHR, PACS, Interoperability, Healthcare Analytics, Telemedicine, CRM), Market Size, Adoption Trends, Competitive landscape (Market Share Analysis, Product Portfolio Assessment) - Global Forecast to 2020
The global healthcare IT solutions market size is projected to grow at a CAGR of 13.4%. This market is mainly driven by the increasing need to curtail healthcare expenditure and growing demand for solutions to increase the quality of care. The growing patient burden on healthcare systems across the globe and subsequent need to improve operational efficiency is also driving the greater adoption of HCIT solutions among healthcare providers.
- Published: August 2016
- Price: $ 4950
- TOC Available:
-
Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030
The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Neurostimulation Market by Product & Applications (2012-2017) (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Transcranial Magnetic, Gastric, TENS) Global Trends, Emerging Applications & Competitive Landscape
This report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector.
- Published: September 2009
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
